Site Members can sign up for company wide alerts
Investigation Overview
April 10, 2012 (Shareholders Foundation) -- An investigation for current investors in shares of Medicis Pharmaceutical Corp (NYSE:MRX) was initiated concerning whether certain officers and directors of Medicis Pharmaceutical Corp breached their fiduciary duties by paying executives excessive compensation. The investigation by a law firm focuses on whether the directors and officers of...
You must register (for free) or login to view the entire investigation.